Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study

Abstract

BackgroundPrevious studies have implicated a vital association between gut microbiota/gut microbial metabolites and low back pain (LBP), but their causal relationship is still unclear. Therefore, we aim to comprehensively investigate their causal relationship and identify the effect of gut microbiota/gut microbial metabolites on risk of LBP using a two-sample Mendelian randomization (MR) study.MethodsSummary data from genome-wide association studies (GWAS) of gut microbiota (18,340 participants), gut microbial metabolites (2,076 participants) and LBP (FinnGen biobank) were separately obtained. The inverse variance-weighted (IVW) method was used as the main MR analysis. Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) and MR-Egger regression were conducted to evaluate the horizontal pleiotropy and to eliminate outlier single-nucleotide polymorphisms (SNPs). Cochran’s Q-test was applied for heterogeneity detection. Besides, leave-one-out analysis was conducted to determine whether the causal association signals were driven by any single SNP. Finally, a reverse MR was performed to evaluate the possibility of reverse causation.ResultsWe discovered that 20 gut microbial taxa and 2 gut microbial metabolites were causally related to LBP (p < 0.05). Among them, the lower level of family Ruminococcaceae (OR: 0.771, 95% CI: 0.652–0.913, FDR-corrected p = 0.045) and Lactobacillaceae (OR: 0.875, 95% CI: 0.801–0.955, FDR-corrected p = 0.045) retained a strong causal relationship with higher risk of LBP after the Benjamini–Hochberg Corrected test. The Cochrane’s Q test revealed no Heterogeneity (p > 0.05). Besides, MR-Egger and MR-PRESSO tests showed no significant horizontal pleiotropy (p > 0.05). Furthermore, leave-one-out analysis confirmed the robustness of MR results. After adding BMI to the multivariate MR analysis, the 17 gut microbial taxa exposure-outcome effect were significantly attenuated and tended to be null.ConclusionOur findings confirm the the potential causal effect of specific gut microbiota and gut microbial metabolites on LBP, which offers new insights into the gut microbiota-mediated mechanism of LBP and provides the theoretical basis for further explorations of targeted prevention strategies.

Investigating causal associations among gut microbiota, metabolites, and psoriatic arthritis: a Mendelian randomization study

“…Thirdly, due to the insufficient number of SNPs available for subsequent MR analysis in the MiBioGen consortium, we opted to include only GM-related SNPs at a slightly higher threshold (1 × 10 –5 ) instead of the conventional threshold (5 × 10 –8 ). This decision was based on a prior publication ( Su et al, 2023 ). However, we did exclude SNPs with F-statistics below 10 to minimize the potential for weak instrument bias and improve the overall robustness of the statistical results ( Burgess and Thompson, 2011 ).…”

Causal association of gut microbiota on spondyloarthritis and its subtypes: a Mendelian randomization analysis

“…Due to the strict threshold ( p < 5.0 × 10 −8 ), only a few instrumental variables were obtained. To increase the number of instrumental variables, a threshold of p < 1.0 ×10 −5 was adopted ( 24 , 25 ). Palindromic SNPs and SNPs not present in the outcomes (AS, PsA, and EA) were excluded from the instrumental variables.…”

Psychological Distress and Meniere's Disease: A Bidirectional Two‐Sample Mendelian Randomization Study

“…To evaluate the potential for reverse causality, we conducted a reverse MR analysis. Since there were limited SNPs for the Reverse MR when selecting IVs with a P ‐value < 5e−08, we relaxed the selection criteria for SNPs to a P ‐value < 1e−5 32‐34 . As mentioned above, to ensure that the included SNPs still meet the requirements for IVs, we also calculated the F‐statistics for all SNPs in the reverse MR analysis.…”